GWAS-related eQTLs across different cancer types
We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
eQTL type
|
tagSNP
|
Gene position (hg19)
|
p-value
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
THCA | cis | rs13191362 | 1 | rs67025553 | chr6:163011552 | PACRG | chr6:163148164-163736523:+ | 0.45 | 7 | 8.92E-12 | Body mass index |
THCA | cis | rs891378 | 1 | rs6702997 | chr1:207502347 | CD55 | chr1:207494817-207534309:+ | 0.15 | 6.66 | 7.54E-11 | Spherical equivalent (joint main effects and education interaction) |
THCA | cis | rs891378 | 1 | rs6703002 | chr1:207502372 | CD55 | chr1:207494817-207534309:+ | 0.15 | 6.6 | 1.11E-10 | Spherical equivalent (joint main effects and education interaction) |
THCA | cis | rs7523455 | 1 | rs6703129 | chr1:19324092 | TMCO4 | chr1:20008707-20126758:- | -0.15 | -3.36 | 0.00083 | Methotrexate phramacokinetics (acute lymphoblastic leukemia) |
THCA | cis | rs6684514 | 1 | rs67034206 | chr1:156270260 | BGLAP | chr1:156182784-156213112:+ | 0.23 | 5.55 | 4.68E-8 | Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels |
THCA | cis | rs6684514 | 1 | rs67034206 | chr1:156270260 | C1orf85 | chr1:156259882-156265449:- | -0.17 | -4.16 | 3.82E-5 | Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels |
THCA | cis | rs6684514 | 1 | rs67034206 | chr1:156270260 | CCT3 | chr1:156278752-156308195:- | -0.33 | -7.21 | 2.16E-12 | Mean corpuscular hemoglobin concentration;Glycated hemoglobin levels |
THCA | cis | rs891378 | 1 | rs6703857 | chr1:207443553 | CD55 | chr1:207494817-207534309:+ | 0.14 | 6.55 | 1.46E-10 | Spherical equivalent (joint main effects and education interaction) |
THCA | cis | rs4915077 | 1 | rs6703923 | chr1:108352252 | VAV3 | chr1:108113782-108507545:- | 0.45 | 7.37 | 7.73E-13 | Hypothyroidism |
THCA | cis | rs13191362 | 1 | rs67042566 | chr6:163006541 | PACRG | chr6:163148164-163736523:+ | 0.46 | 7.08 | 5.13E-12 | Body mass index |
THCA | cis | rs13191362 | 1 | rs67046187 | chr6:163068532 | PACRG | chr6:163148164-163736523:+ | 0.52 | 7.34 | 9.39E-13 | Body mass index |
THCA | cis | rs9677476 | 1 | rs6704770 | chr2:232109816 | ARMC9 | chr2:232063342-232238606:+ | 0.43 | 10.4 | 5.65E-23 | Food antigen IgG levels |
THCA | cis | rs4665809 | 1 | rs6704930 | chr2:26325705 | GPR113 | chr2:26531041-26569685:- | -0.42 | -6.71 | 5.42E-11 | Gut microbiome composition (summer) |
THCA | cis | rs2241437 | 1 | rs6705122 | chr2:86176258 | LOC90784 | chr2:86247339-86250991:- | -0.29 | -3.39 | 0.000754 | Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure) |
THCA | cis | rs2241437 | 1 | rs6705122 | chr2:86176258 | POLR1A | chr2:86253453-86333278:- | -0.21 | -3.35 | 0.000878 | Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure) |